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1. Introduction   
The most common histopathological classification of chronic hepatitis was determined by 
descriptive terms, which included a subjective factor of histopathological description. It 
might have caused a lot of interpretative discrepancies among diagnosticians dealing with 
chronic liver inflammation. These difficulties led sometimes to inappropriate treatment 
protocol, such as the use of interferon, or caused discrepancies in the morphological rating 
of treatment efficiency. The first attempt of rating liver specimens in an objective way was 
Histological Activity Index (HAI), reported in 1981 by Knodell et al. Subsequently, many 
locally used modifications have been created (Lindh, Scheuer, Batts&Ludwig, Ishak, 
Gabriel, METAVIR). It made chronic hepatitis classification much more objective and helped 
in statistical analysis of research results. New diagnostic criteria of chronic liver diseases 
prepared in 1984 by the World Congress of Gastroenterology and International Association 
for the Study of the Liver (IASL) prompted authors to update previously used classifications 
(International Working Party, 1994). The purpose of this study is to optimize the clinical 
data necessary in proper diagnosis, taking into account the new criteria of inflammatory 
activity, process of fibrosis and steatosis.   
2.1 Clinical part of the protocol 
The points of the protocol relating to the anamnesis are to determine the nature of the 
disease – acute or chronic – in accordance with definition based on time criterion 
proposed by Leevy in 1976 (Leevy et al., 1976). Additionally, anamnesis should lead to the 
detection of two or more coexisting etiologic factors, for example infection with two 
hepatitis viruses. The protocol also considers the source of infection, as this factor may be 
important in determining prognostic significance, such as perinatal HBV/HCV infection, 
which leads to chronic state and increases the probability of developing primary liver 
cancer in adulthood. 
The authors propose to include five hepatotrophic viruses into the protocol. Knowledge and 
description of the viruses will help in development of serological and immunological tests. 
Viral factors can be detected using: 
 Indication of viral markers by immunoassay and radioimmunoassay methods (EIA and 
RIA), 
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 Polymerase Chain Reaction (PCR) in the serum, 
 Fluorescence in situ hybridisation (FISH) or chromogenic in situ hybridization (CISH) 
 Measurement of viral genetic material (RNA, DNA) in the serum (RT-PCR). 
A large number of liver lesions are caused by toxic agents such as alcohol and long-term 
drug use. This aspect requires special attention in anamnesis. Less common etiologic factors 
in adults, but more common in children are congenital metabolic disorders such as:   
α1-antiprotease (α1-antitrypsin) deficiency, storage diseases, galactose intolerance or 
abnormal metabolism of copper and iron. 
Laboratory test are divided into three groups: 
 non-specific tests of liver parenchymal necrosis, 
 tests to assess liver viability, 
 general tests of the inflammatory process. 
Radiological procedures, such us abdominal ultrasonography, bile ducts X-ray 
(cholecystography, cholangiography), magnetic resonance imaging (MRI) and computed 
tomography (CT) are the main sources of knowledge relating to the size of the liver, 
presence of focal lesions and some of the extrahepatic bile ducts malfunctions. If liver biopsy 
is performed earlier, its results should be attached. This knowledge simplifies proper 
diagnosis and enables assessment of the dynamics of the inflammatory and fibrotic process. 
The summary of the clinical part of the protocol is to establish preliminary diagnosis causing 
liver dysfunction. If the diagnostician is unable to establish the etiology of the disease it is 
possible to conduct research with additional selective histopathological techniques, such as 
immunohistochemical analysis of liver tissue performed using sera containing monoclonal 
antibodies to detect viral antigens. It is possible to use other specific techniques, PCR or 
hybridization in situ, to detect viral nucleic acids. If the clinical data is not complete and 
morphological picture is not characteristic, descriptive morphological diagnosis should be 
used. When there is the suspicion of morphological abnormalities the test for the presence of 
iron or copper can be performed. 
2.2 Morphological part of the protocol 
Morphological protocol describes necro-inflammatory activity, fibrosis and degenerative 
alteration of hepatocytes. 
Grading for necro-inflammatory activity is based on a 4-point scale assessing the intensity of 
inflammatory and necrotic process – piecemeal necrosis including bridging necrosis, focal 
lobular necrosis and portal inflammation. The primary grading scoring system for necro-
inflammatory activity proposed by Batts (Table 1) was modified by a group of Polish 
hepatologists and introduced to the protocol (Batts&Ludwig 1995, Gabriel et al., 1999). 
Piecemeal necrosis is a specific morphological change produced by a cytotoxic reaction of 
lymphocytes to hepatocytes. It is the death of hepatocytes at the margin of the lobule which 
is associated with the destruction of the limiting plate. The process extends piecemeal 
towards the centre of the lobule. Lymphocytes are seen adjacent to the damaged 
hepatocytes. The severity of lobular necrosis may encompass changes from a single foci of 
lymphocytic or lymphocytic-granulocytic infiltration (without hepatocyte death), through 
inflammatory-cell infiltration with single hepatocyte destruction to advanced confluent 
bridging necrosis  involving a considerable portion of lobular surface with the associated 
collapse of the lobular stroma or perivenular confluent necrosis. The assessment of the 
intensity of inflammatory infiltration in portal spaces was not taken into consideration due 
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to less prognostic significance and difficulties in objective assessment. This category of 
portal inflammation, according to Theise, is inappropriate for clinical evaluation as it is a 
defining lesion for chronic hepatitis. Furthermore, prominent lymohoid aggregates or 
follicles of hepatitis C might falsely inflate the severity of necroinflammatory activity 
compared to conditions where such lymphoid follicles are much less typical (chronic 
hepatitis B, autoimmune cholangitis, primary biliary cirrhosis) (Theise 2007). The presence 
of degenerative and regenerative changes in hepatocytes is an additional element 
accompanying inflammatory infiltrations and/or necrosis. It seems that these changes are of 
minor importance in determining the inflammatory activity and are secondary to necrosis 
and inflammation. 
 
Grading Terminology Criteria 
Semiquantitative Descriptive 
Lymphocytic 
piecemeal necrosis 
Lobular inflammation 
and necrosis 
0 
Portal 
inflammatory 
only, no activity 
None None 
1 Minimal Minimal, patchy 
Minimal; occasional 
spotty necrosis 
2 Mild 
Mild; involving  
some or all  
portal tracts 
Mild; little 
hepatocellular damage 
3 Moderate 
Moderate; involving 
all portal tracts 
Moderate; noticeable 
hepatocellular damage 
4 Severe 
Severe; may here 
bridging necrosis 
Severe; prominent 
diffuse hepatocellular 
damage 
Table 1. Grading of disease activity in chronic hepatitis (Batts&Ludwig) 
Another part of the protocol is the assessment of the intensity of fibrotic process - staging. 
The evaluation of fibrosis staging is based on a 4-point scale proposed by Batts&Ludwig. 
There are also other semi-quantitative scoring systems by METAVIR, Knodel, Desmet or 
Scheuer used to assess hepatitis activity but of local significance and usage. The comparison 
of scoring systems used by different authors for staging of chronic hepatitis is presented in 
Table 2. This parameter can be accurately assessed in histopathological sections after 
additional histochemical staining techniques for the detection of collagen fibers, such as 
Azan and Masson’s trichrome. When pathological fibrosis is present in the liver tissue, both 
the number of actively formed collagen fibres and their location should be determined to 
assess its severity. The term ‘portal fibrosis’ refers to the involvement in the process of 
collagen fibroplasia of portal tracts alone. Periportal fibrosis means the presence of collagen 
fibres in portal tracts and their extension into the lobules or formation of single fibrous 
bridges which connect the adjacent portal tracts (portal-portal fibrosis). Bridging fibrosis is 
the presence of fibrous bridges which connect the adjacent portal tracts or portal tracts and 
the central venule, which leads to architectural distortion. Bridging fibrosis and nodular 
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regeneration correspond to stage 4 of histopathological severity. Proposed protocol does not 
include the scoring system proposed by Desmet, which differentiated the occurrence of 
porto-portal and porto-central septa as separate stages. The latter was attributed as playing 
a greater importance in the development of cirrhosis (Desmet 1994). The authors have 
added the description of advanced vascular changes to this point after consideration of the 
submitted proposals. It is of great importance in describing specimens of transplanted liver, 
especially during chronic graft rejection process. It is also useful in the evaluation of portal 
hypertension. 
 
 
Score Description 
Knodell et al. 
(1981) 
Desmet et al. 
(1994) 
Scheuer (1991) 
0 No fibrosis No fibrosis None None 
1 Mild fibrosis 
Fibrosis portal 
expansion 
Periportal fibrous 
expansion 
Enlarged, fibrotic 
portal tracts 
2 
Moderate 
fibrosis 
 
Porto-portal septa   
( ≥ 1 septum) 
Periportal or portal-
portal septa, but 
intact architecture 
3 
Severe 
fibrosis 
Bridging fibrosis 
(portal-portal or 
portal-central 
linkage) 
Porto-central 
septa     
 ( ≥ 1 septum) 
Fibrosis with 
architectural 
distortion, but no 
obvious cirrhosis 
4 Cirrhosis Cirrhosis Cirrhosis 
Probable or definite 
cirrhosis 
Table 2. Scoring systems for staging of chronic hepatitis. 
Additional morphological features of lesser importance are ballooning degeneration, 
steatosis, cholestasis, bilirubinostasis, state of bile in ducts and ductules. The presence of 
ballooning degeneration and steatosis may indicate toxic damage or metabolic disorders 
such as non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH). 
Determining the degree of steatosis is important in liver transplant eligibility. 70% of cases 
of infections with HCV (mostly genotype 3a HCV) is associated with the presence of 
steatosis. Hepatic steatosis in the course of chronic hepatitis C is one of the risk factors for 
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fibrosis progression. Moreover, steatosis decreases the rate of sustained response for 
antiviral therapy.   
Estimation of steatosis extent with numerical semi-quantitative assessment is commonly 
used in NAFLD. Many scoring scales were proposed. Currently the most widely used are 
the scales proposed by Brunt, Kleiner, Mendler and Dixon. The scoring system proposed by 
Kleiner et al. estimating NAFLD activity score (NAS) seems to be most suitable due to its 
simple and clear grading of steatosis and ballooning degeneration. The scoring scale 
proposed by Kleiner et al. is presented in Table 3. 
 
NAFLD Activity Score (NAS) (0-8) 
Sum of scores for steatosis, lobular inflammation and hepatocellular ballooning. 
Steatosis (0-3) 
0 - 5% hepatocytes involved 
1 – 5-33% of hepatocytes 
involved 
2 - 33-66% hepatocytes involved
3 - >66% hepatocytes involved 
Hepatocyte ballooning (0-2)
0 – none 
1 – few ballooned cells 
2 – many cells / prominent 
ballooning 
Lobular inflammation (0-3) 
0 – none 
1 - <2 foci per x 200 field 
2 – 2-4 foci per x 200 field 
3 - >4 foci per x 200 field 
Correlation between total NAFLD activity scores and an overall histological diagnosis  
of steatohepatitis 
NAFLD activity score Histological diagnosis of steatohepatitis 
≥5   Probable or define NASH 
3-4   Uncertain NASH 
≤2   Not NASH 
Table 3. Scoring system according to Kleiner et al.  
Cholestasis is usually observed in chronic biliary diseases such as primary liver cirrhosis, 
primary sclerosing cholangitis and autoimmune cholangitis. Cholestasis in acute phase of 
infection is typical for viral infections, but it occurs rarely during chronic and autoimmune 
hepatitis. Accurate assessment of biliary tracts within portal spaces is important for 
determining the stage of primary biliary cirrhosis, primary sclerosing cholangitis and 
autoimmune processes of destruction of the bile ducts during chronic graft rejection. 
Regenerative proliferation of bile ductules is accompanied by advanced changes in organ 
architecture in cases of chronic inflammations with high activity and in the course of cirrhosis. 
The last point of the morphological protocol is biopsy-point rating, which seems to be useful 
for statistical evaluation of process activity. A justified criticism of the approach proposed 
by Knodell et al. is that it incorporates necro-inflammatory activity and fibrosis into an 
overall grade (Knodell et al., 1981). This implies that these two histological features increase 
in parallel to each other. The morphological component of the protocol involves a detailed 
description of the specimen, which helps for proper interpretation by the clinician. The last 
point of the protocol is to establish a final diagnosis with the use of descriptive terminology 
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(hepatitis with minimal, mild, moderate, severe inflammatory activity [grade], portal, 
periportal, septal fibrosis, cirrhosis [stage]).  
There are several possibilities as to how to compose the final conclusion: 
a. The unequivocal histopathological picture is indictive for… 
b. The histopathological picture, aside from the clinical data, can lead to diagnosis.  
c. The unequivocal diagnosis is not possible due to i.e. disintegrated material, improper  
fixing of material, non-representative material.  
If the etiology is unknown, the pathologist may propose additional tests. When the clinical 
data is not complete, the morphological picture is not characteristic or specimen is 
insufficient for certain diagnosis – the biopsy specimen is shorter than 25 mm or includes 
less than 11 portal tracts – delineation of morphological features and alterations should be 
carried out. Staging and grading is allowed only for the assessment of biopsy specimens 
which fulfill all of the above mentioned criteria. 
Additional tests can be performed in the case of morphological abnormalities - the Prussian 
blue reaction in Perl's test for iron presence, rhodamine according to Lindqvist for copper 
deposits, PAS following digestion with diastase for α1-antiprotease. 
Results of prior biopsy should be attached. This allows for the assessment of the dynamics 
of the inflammatory or fibrotic process. 
The summary of the clinical part of the protocol is to establish preliminary diagnosis of liver 
dysfunction.  
If the diagnostician is unable to establish the etiology of the disease, it is possible to conduct 
research with additional selective histopathological techniques, such as immunohistochemical 
analysis of liver tissue performed using sera containing monoclonal antibodies to detect viral 
antigens. It is possible to use other specific techniques, PCR or hybridization in situ, FISH and 
CISH to detect viral nucleic acids.  
2.3 Difficulties in the differential diagnosis of chronic hepatitis 
So far, pathologists have generally determined the degree and extent of hepatitis activity or 
progression of disease. Lobular inflammatory cell infiltration tends to predominate in acute 
phases of hepatitis, while portal and periportal inflammation is characteristic of chronic 
state. Portal hepatitis is a frequent form of chronic inflammation, consisting of infiltrations 
which comprise lymphocytes, plasma cells and macrophages. Plasma cells are predominant 
in autoimmune hepatitis alongside destruction of bile ducts with lymphocytic infiltration. 
Aggregates of lymphocytes or lymph follicles are observed in approximately 50% of chronic 
hepatitis C patients. When portal hepatitis is not accompanied by periportal or lobular 
infiltrations, the process is described as non-active. When periportal hepatitis is associated 
with focal hepatocyte destruction, the process is termed piecemeal necrosis. Mild 
inflammation, involving portal tracts is known as portal hepatitis. It is difficult to 
differentiate between true chronic hepatitis and non-specific hepatitis, or reactive chronic 
hepatitis, which accompanies a number of systemic diseases. When piecemeal necrosis or 
marked lobular necrosis coexists with inflammatory cells infiltrations, chronic hepatitis 
should be suspected. Marked fibrosis (septal fibrosis/cirrhosis) suggests chronic hepatitis or 
chronic biliary disease. If mild inflammatory infiltration in portal tracts exists as separate 
alteration, the condition is described as chronic reactive hepatitis.  The diagnosis of chronic 
liver disease cannot be stated only on the basis of histopathological assessment and must be 
supported by clinical data (disease duration at least 6 months). 
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2.4 Proposed protocol for  histopathological examination of liver biopsy specimen  
 
ID History   
First Name  
Address: Last name  
Date of birth  
(Preliminary) Clinical diagnosis  
Since when has he/she been ill? 
(month, year) 
 
Has he/she ever suffered from 
hepatitis? (year) 
  
What type? (if documented)   
The way of infection   
Completed hepatitis vaccination   
Other diseases 
metabolic diseases   
other   
BMI kg/m2 Height cm 
Body weight kg Waist circumference cm 
  Hip circumference cm 
Drugs used: 
Actually   
Formerly   
Alcohol 
 (average amount per week)  
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Etiological factors examined 
(serological methods and molecular biology) 
HBV HCV HDV Others 
HBsAG  … 
Anty HBs … 
HBeAg … 
Anty HBe … 
Anty HBc … 
DNA-HBV (PCR) … 
HBV-DNA (pg/ml) … 
Anty HCV … 
RNA HCV(PCR) … 
Viral genotype    … 
Viral load (IU/ml) … 
Anty HDV … 
 
RNA-HDV(pg/ml)          ….
HAV … 
HGV … 
 
HIV … 
CMV … 
HSV … 
 
 
 
Radiology  (USG, CT, MRI, bile ducts X-ray) 
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Laboratory tests 
 
pANCA 
 
ANA   …………… 
SMA   …………… 
LKM-1  …………… 
AMA  …………… 
IgG  …………… 
α1 AT level …………… 
 
 
Total protein ……………………… 
Albumin: ……………………… 
Globulin: 
 ǂ1 ……………………… 
 ǂ2 ……………………… 
 ǃ ……………………… 
 Ǆ ……………………… 
a) parenchymal necrosis tests:  
 ALT ……………… AST   ……………… 
b)  
alkaline phosphatase  ………… GGTP ………… bilirubin …………… 
TIBC  ………… Fe ………… ferritin  …………… 
cholesterol  ………… HDL ………… LDL  ……………. 
triglycerides  ………… ceruloplasmin   ………… glucose   ……………. 
c) blood morphology  
RBC ………… WBC ………… Neutrophils …………… 
HGB  …………  Lymphocytes  …………… 
HCT  …………  Monocytes  …………… 
MCV  ………… PLT ………… Eosynophils  …………… 
d) inflammatory process test  
 CRP ……………… 
Erythrocyte  
sedimentation rate        ………………  
e) coagulation  
INR ……………… 
prothrombin  
index  ……………… 
fibrinogen     ……………… 
 
Short course of the disease: results of the former liver biopsy (Nr…  Date…) 
 
date and signature of physician 
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Histopathology 
 
Immunohistochemical and in situ hybridisation tissue tests: 
Etiologic factors………………………………………………………………….. 
HBsAg……  HCVAg………………  HBV DNA (PCR/CISH or FISH) 
HBcAg………  HDVAg………………  HCV RNA (PCR/CISH or FISH) 
HBeAg……… 
Staining for the presence of:  Fe………… Cu…………… α1- antiprotease……………… 
 
 
Inflammatory activity grade 
Criteria
Score * piecemeal necrosis-range lobular inflammation and necrosis 
0  none none 
1 minimal single 
minimal grade inflammation, single 
focal necrosis 
2 mild occupying single portal areas 
low grade inflammation, slight 
destruction of hepatocytes 
3 moderate occupying all portal areas 
moderate grade inflammation, 
noticeable destruction of    
hepatocytes 
4 severe occupying all portal areas  
high grade inflammation, prominent 
diffuse hepatocellular 
damage, the presence of bridging or 
perivenular necrosis 
 
Regressive changes in hepatocytes 
Ballooning degeneration grade…………… 
Score** 
Steatosis grade…………… 
Score** 
0 –  none 0 –  <5%  hepatocytes involved 
1 –  few ballooned cells 1 –  5-33%  hepatocytes involved 
2 –  many cells or prominent 
 ballooning 
2 –  33-66%  hepatocytes involved 
 
 
3 –  >66%  hepatocytes involved 
 
Regenerative changes in hepatocytes (dysplasia)…………………………………… 
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Stage of fibrosis 
Score * Fibrosis Criteria 
0 no fibrosis normal amount of connective tissue 
1 fibrosis of portal  area occupation of portal areas by fibrosis 
2 periportal fibrosis 
periportal fibrosis or single bridges 
portal-portal 
3 bridging fibrosis 
many fibrous bridges with distortion 
of hepatic architecture 
4 cirrhosis cirrhosis 
 
Cholestasis and bilirubinostasis……………………………………… 
Changes in vessels……………………………. 
 
Scoring 
     
inflammation …    steatosis …        ballooning … fibrosis … 
 
Histopathological description: 
 
 
     
Additional studies proposed ……………………………………………………….  
 
Final diagnosis ………………………………………………………. 
 
In descriptive terminology ………………………………………………………. 
 
Proposed differentiation  ………………………………………………………. 
 
  
date and signature of physician 
*According to modified Batts & Ludwig scoring system 
** According to Kleiner scoring system 
3. Conclusion 
A standardized universal protocol of liver biopsy such as the proposed scheme will facilitate 
the diagnosis of patients with suspected chronic liver disease. Obtaining complete and 
accurate clinical data by pathologists will allow more precise interpretation of observed 
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histological findings and will point to the necessity of additional tests. The histopathological 
picture should be assessed independently by two experienced pathologists in the case of 
research. In normal practice assessment by one experienced hepato-pathologist is accurate. 
In the future, in the final version of the protocol, histopathological data should be stored in a 
database especially prepared for pathologists. 
The prevalence of this protocol will unify the terminology used so far and will reduce 
differences in interpretation between the various centers. Modern treatment of chronic liver 
diseases is very expensive, especially in the case of viral infections. It requires a strict 
eligibility of patients for therapy. We hope that application of this protocol will assist in the 
proper use of financial resources thus leading to an increase in the number of complete 
recoveries. 
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